Skip to main content

Fiscal Wizard · Single-issue tearsheet

CAH / Aug 31, 2026 Run #19077

CAH

Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Composite verdict

B 60.3 / 100
Bullish setup · Reversal 8 drivers · 2 gates blocking
  • Elder Force Index
  • ADX DI Cross
  • Stochastic Cross
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 2nd of 4 in Medical Distribution

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 23 signals0% Bear
Momentum Bullish 92Mean-reversion Neutral 57

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from
Asset value $-11.96Earnings power value $63.52Price $236.02

Priced above its no-growth earnings power value ($63.52/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

20.7 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
P/E (TTM) 0
Asset Turnover 100
Operating Margin 0
Greenblatt ROC 100
OCF to Net Income 0

Technicals Bullish

99.9 / 100

Bullish setup leads (Elder Force Index, ADX DI Cross, Stochastic Cross); bears gated by guards. · 44 signals shown.

Strongest
Weakest
Elder Force Index 91
ADX DI Cross 87
Stochastic Cross 87

Risk Gates

2 blocking 8 caution

2 guards active, 20 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Beneish M-Score Caution

Bottom-band Beneish M blocks bullish signals — accounting-quality risk.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CAH.